West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

Currently, West Pharmaceutical Servs shares are trading up 2.21%, priced at $208.15 during Friday's morning. This values MacKay's 0 shares at $0.

We recently published a list of These Were Last Week’s 10 Worst Performers. In this article, we are going to take a look at ...

CIBC Asset Management Inc raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.5% in the fourth quarter, HoldingsChannel reports. The firm owned 11,058 ...

The latest update on Friday morning shows West Pharmaceutical Servs shares up by 2.21%, trading at $208.15. At this price, Reiss-Clark's 0 shares are worth $0.

West Pharmaceutical’s earnings results led to a 38% drop. Find out why WST stock could be worth watching for future rebounds ...

What Happened? Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon ...

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its stock performance has been volatile, with annual returns of 66% in 2021, ...

West Pharmaceutical Services, Inc. (NYSE:WST) reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72 ...

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST ) and is included on the Standard & ...

West Pharmaceutical Services stock sank Thursday after the company issued a full-year outlook that missed analysts’ expectations. Shares plunged 31% to $222.46, putting them on pace for their worst ...

Shares of West Pharmaceutical Services Inc. WST shed 4.03% to $202.49 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.24% ...